Sign in

CIK 0001730430 · Large accelerated filer

Kiniksa Pharmaceuticals International, plc

Sign in to watch
Ticker
KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981795578
Phone
7814319100
Business address
105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
Former names
Kiniksa Pharmaceuticals, Ltd.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$78,588,440
in 8 filings, $78.6M under 10b5-1 plans

Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
  2. Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
  3. Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
  4. Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
  5. Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Date Insider Transaction Shares Price Value Owned after
2020-02-19 Paolini John F. SVP & Chief Medical Officer Sale −22,477 $18.27 $411K 18,000
2020-02-19 Paolini John F. SVP & Chief Medical Officer Option exercise · Share Option −22,477 76,345
2020-02-14 Beetham Thomas W. EVP & Chief Legal Officer Sale −59 $18.58 $1K 79,530
2020-02-14 Paolini John F. SVP & Chief Medical Officer Option exercise +1,039 $3.80 $4K 19,039
2020-02-14 Paolini John F. SVP & Chief Medical Officer Sale −1,039 $18.33 $19K 18,000
2020-02-14 Paolini John F. SVP & Chief Medical Officer Option exercise · Share Option −1,039 98,822
2020-02-13 Paolini John F. SVP & Chief Medical Officer Option exercise +10,277 $3.80 $39K 28,277
2020-02-13 Paolini John F. SVP & Chief Medical Officer Sale −10,277 $18.29 $188K 18,000
2020-02-13 Paolini John F. SVP & Chief Medical Officer Option exercise · Share Option −10,277 99,861
2019-12-12 Rizvi Qasim Chief Commercial Officer Grant or award · Restricted Share Units +7,337 7,337
2019-12-06 Rizvi Qasim Chief Commercial Officer Grant or award · Class A Common Shares +30,000 30,000
2019-12-05 Paolini John F. SVP & Chief Medical Officer Option exercise +8,000 $1.86 $15K 8,000
2019-12-05 Paolini John F. SVP & Chief Medical Officer Option exercise · Share Option −8,000 209,574
2019-10-07 Paolini John F. SVP & Chief Medical Officer Option exercise +10,000 $1.86 $19K 10,000
2019-10-07 Paolini John F. SVP & Chief Medical Officer Option exercise · Share Option −10,000 217,574
2019-09-17 Mahoney Stephen F. President & COO Grant or award · Share Option +82,000 82,000
2019-09-17 Beetham Thomas W. EVP & Chief Legal Officer Grant or award · Share Option +45,000 45,000
2019-09-17 Patel Sanj K Chairman & CEO Grant or award · Share Option +190,000 190,000
2019-09-17 Heberlig Chris EVP & CFO Grant or award · Share Option +50,000 50,000
2019-09-17 Paolini John F. SVP & Chief Medical Officer Grant or award · Share Option +46,000 46,000

Page 76 of 80 · 1,595 trades